Cargando…
Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non‐small‐cell lung cancer patients
Immunotherapy against cancer, through immune checkpoint inhibitors targeting the programmed cell death‐1/programmed cell death‐ligand 1 axis, is particularly successful in tumors by relieving the immune escape. However, interindividual responses to immunotherapy are often heterogeneous. Therefore, i...
Autores principales: | Zhang, Chufeng, Wang, Jixin, Sun, Zhongwen, Cao, Yufeng, Mu, Zhengshuai, Ji, Xuming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353904/ https://www.ncbi.nlm.nih.gov/pubmed/34028936 http://dx.doi.org/10.1111/cas.14979 |
Ejemplares similares
-
Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors
por: Daillère, Romain, et al.
Publicado: (2020) -
The Commensal Microbiota Drives Immune Homeostasis
por: Arrieta, Marie-Claire, et al.
Publicado: (2012) -
The gut microbiota and immune checkpoint inhibitors
por: Humphries, Audrey, et al.
Publicado: (2018) -
Immunomodulation by the Commensal Microbiome During Immune-Targeted Interventions: Focus on Cancer Immune Checkpoint Inhibitor Therapy and Vaccination
por: Reens, Abigail L., et al.
Publicado: (2021) -
Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota
por: Wen, Minting, et al.
Publicado: (2023)